Picture of Mustang Bio logo

MBIO Mustang Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Mustang Bio Inc MBIO.OQ reported a quarterly adjusted loss of $37.95​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-43.00.  The lone analyst forecast for the quarter was for a loss of $8.00 per share.

Reported revenue was zero​; analysts expected zero.

Mustang Bio Inc's reported EPS for the quarter was a loss of $37.95​.

The company reported a quarterly loss of $952 thousand.

Mustang Bio Inc shares had fallen by 84.0% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

This summary was machine generated from LSEG data March 28 at 01:27 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Dec. 31 2024-8.00-37.95Missed
Sep. 30 2024-6.50-2.00Beat

Recent news on Mustang Bio

See all news